It is known that significant differences exist in the mechanisms of CD155 in cancer progression; however, clinical evidence collected and analyzed in this meta-analysis strongly suggested that CD155 played an effective role in cancer development, and CD155 might ultimately act as a pro-oncogenic factor in tumorigenesis. This evidence concerns the gene PVR and cancer.